-
5m 53sPart 2 | Session 3 VERITAS Study: Next-Generation LAA Closure with Amulet 360
-
3m 48sPart 2 | Session 4 STYLE AF Update: Venous Vascular Closure in AF Patients
-
4m 50sPart 2 | Session 5 Balloon-in-Basket PFA without Propofol
-
5m 58sPart 2 | Session 6 ADVENT LTO: Long-Term PFA Outcomes and AF Progression
-
4m 16sPart 3 | Session 1 4 Trials That Will Change My Practice with Dr Luigi Di Biase
-
5m 18sPart 3 | Session 2 AF & EP in 2026: Five Things That Will Change Daily Practice
-
10m 44sPart 1 | Session 1 Complication Prevention in Complex AF and VT Procedures
-
12m 35sPart 1 | Session 2 Will PFA Redefine AF Ablation Strategies in 2026?
-
9m 39sPart 1 | Session 3 Redo AF Ablation: When to Go Beyond PVI?
-
4m 10sPart 2 | Session 1 Stroke Management After AF Ablation
Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) joins us to discuss findings from the VOLT AF IDE trial, evaluating a novel balloon-in-basket pulsed field ablation system that integrates mapping and ablation capabilities.
The prospective, multicenter VOLT AF IDE study evaluated safety and effectiveness of the Volt™ PFA system in patients with symptomatic, recurrent, drug-refractory paroxysmal and persistent atrial fibrillation, examining acute procedural outcomes, efficiency gains, and freedom from arrhythmia recurrence.
Interview Questions:
- Tell us about balloon-in-basket PFA – what is the idea behind the design?
- What did we learn from the VOLT AF IDE trial readout?
- How much time are we saving by mapping and ablating with the same tool?
Recorded on-site at AF Symposium 2026, Boston.
Editor: Jordan Rance
Videographer: David Ben-Harosh
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2026 in Boston. Don't miss our short, accessible Expert Interviews, Discussions and Highlights of the most pertinent trials.
More from this programme
Part 1
Clinical Discussions
Part 2
Expert Interviews
Faculty Biographies
Atul Verma
Director of Cardiology
Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA.
Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.
Comments